Many studies reported that reduced E-cadherin expression was significantly associated with poor overall survival of gastric cancer patients [37–39], while quite a few researchs concluded that E-cadherin was not a prognostic factor for survival [40–42]. Here, CDH1 is linked to gastric cancer.